Events3rd International Electronic Conference on Medicinal Chemistry
Published
This submission belongs to the session A. ECMC-3 of the event 3rd International Electronic Conference on Medicinal Chemistry
Published date
01 Nov, 2017
Citation
Martin Mangold, Michael Gütschow, Marit Stirnberg, A Short Peptide Inhibitor as an Activity-Based Probe for Matriptase-2, in Proceedings of 3rd International Electronic Conference on Medicinal Chemistry, 1 November–30 November 2017, MDPI: Basel, Switzerland, doi: 10.3390/ecmc-3-04705
Share
Email
Facebook
Twitter
LinkedIn

A Short Peptide Inhibitor as an Activity-Based Probe for Matriptase-2

image
Marit Stirnberg 1
1. Pharmaceutical Institute, Pharmaceutical Chemistry I, University of Bonn
Abstract

Matriptase-2 is a type II transmembrane serine protease and the key regulator of systemic iron homeostasis. After its synthesis, matriptase-2 is present on the cell surface as an inactive zymogen which is activated by processing. Two processing steps lead to the release of a 55 kDa enzymatically active fragment of the protein into the cell culture supernatant. Since the underlying mechanism of these processing steps is not yet fully understood there is strong need for analytical tools that help to distinguish active and inactive matriptase-2. For this purpose, we present a short biotinylated peptide probe with a chloromethyl ketone group as an inhibitor and activity-based probe for matriptase-2. This probe was characterized in kinetic experiments and applied for in-gel detection of matriptase-2.

Keywords
matriptase-2
activity-based probe
chloromethyl ketone
Manuscript
Poster
MM_MG_MS_ECMC_2017.pdf
Diversity of Bioactive Endophytic Streptomyces sp. Residing in a Common Weed, Parthenium hysterophorus (Asteraceae: Heliantheae)
Fragments of Peptoid 1:Synthesis of N-Substituted Glycine Monomers